-
Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.
Cancer Metastasis Rev. 1988 Jun;7(2):143-88
PMID: 3293836
-
Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Cell Immunol. 1993 Nov;152(1):186-99
PMID: 7694807
-
Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
J Cell Physiol. 1994 Aug;160(2):275-86
PMID: 7518822
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5
PMID: 5432063
-
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.
J Exp Med. 1990 Jul 1;172(1):69-75
PMID: 2193100
-
Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells.
Oncogene. 1994 Feb;9(2):417-23
PMID: 7507229
-
Distinct effects of two CD44 isoforms on tumor growth in vivo.
J Exp Med. 1991 Oct 1;174(4):859-66
PMID: 1919439
-
Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.
Br J Cancer. 1993 May;67(5):910-21
PMID: 8494724
-
Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5143-7
PMID: 3474646
-
The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.
Cancer Res. 1993 Mar 15;53(6):1262-8
PMID: 8443806
-
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation.
Cell. 1995 Jul 14;82(1):19-26
PMID: 7541721
-
Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Cancer Res. 1994 Jul 15;54(14):3922-8
PMID: 7518345
-
Significance of CD44 gene products for cancer diagnosis and disease evaluation.
Lancet. 1992 Oct 31;340(8827):1053-8
PMID: 1357452
-
Topological and quantitative-analyses of early events in tumor-formation using histochemically-tagged transformed 3t3 cells.
Oncol Rep. 1994 Sep;1(5):869-76
PMID: 21607457
-
The hyaluronate synthase from a eukaryotic cell line.
Biochem J. 1993 Mar 15;290 ( Pt 3):791-5
PMID: 8457208
-
Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
Cancer Res. 1993 Sep 15;53(18):4197-203
PMID: 7689929
-
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.
Cell. 1991 Apr 5;65(1):13-24
PMID: 1707342
-
A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Cancer Res. 1993 Apr 1;53(7):1516-21
PMID: 8453616
-
Putative preneoplastic foci in the human prostate.
J Cell Biochem Suppl. 1994;19:224-31
PMID: 7529854
-
CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
Cancer Res. 1994 Aug 1;54(15):4238-42
PMID: 7518353
-
Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
Exp Cell Res. 1993 Aug;207(2):277-82
PMID: 7688314
-
Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
Cancer Res. 1993 Oct 15;53(20):4754-6
PMID: 7691404
-
Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
Cancer Res. 1988 Sep 1;48(17):4941-53
PMID: 3409227
-
Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis.
Exp Cell Res. 1993 Feb;204(2):171-80
PMID: 8382620
-
Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Cancer Res. 1994 Aug 15;54(16):4539-46
PMID: 7519124
-
CD44 and its interaction with extracellular matrix.
Adv Immunol. 1993;54:271-335
PMID: 8379464
-
High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes.
Am J Pathol. 1992 Dec;141(6):1331-42
PMID: 1466397
-
CD44--a new prognostic marker for neuroblastoma.
N Engl J Med. 1993 Dec 23;329(26):1965
PMID: 7504209
-
Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.
Cancer Res. 1991 Dec 15;51(24):6660-7
PMID: 1742741
-
Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression.
Cancer Res. 1990 May 1;50(9):2808-17
PMID: 2183931
-
The implications of angiogenesis for the biology and therapy of cancer metastasis.
Cell. 1994 Oct 21;79(2):185-8
PMID: 7525076
-
Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression.
Int J Cancer. 1991 Apr 22;48(1):148-59
PMID: 2019453
-
Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures.
J Exp Med. 1990 Feb 1;171(2):477-88
PMID: 2406365
-
Modulation of tumor cell response to chemotherapy by the organ environment.
Cancer Metastasis Rev. 1994 Jun;13(2):209-22
PMID: 7923551
-
The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.
J Cell Biol. 1992 Feb;116(4):1055-62
PMID: 1370836
-
Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
Cancer Res. 1994 Mar 15;54(6):1561-5
PMID: 7511044